Recent Patents on Anti-Cancer Drug Discovery


Khurshid Zaman  
Bentham Science Publishers


Abstract Ahead of Print

TC > 0.05 as a Pharmacokinetic Parameter of Paclitaxel for Therapeutic Efficacy and Toxicity in Cancer Patients

D. S. Xin, L. Zhou, C. Z. Li, S. Q. Zhang, H. Q. Huang, G. D. Qiu, L. F. Lin, Y. Q. She, J. T. Zheng, C. Chen, L. Fang, Zhe-Sheng Chen* and S. Y. Zhang

Stemness Phenotype in Tamoxifen Resistant Breast Cancer Cells may be induced by Interactions between Receptor Tyrosine Kinases and ERα-66

Leila Farahmand, Sepideh Mansouri, Narges Jafarbeik-Iravani, Azin Teymourzadeh and Keivan Majidzadeh-A*

Oral Submucous Fibrosis as an Overhealing Wound: Implications in Malignant Transformation

Mohit Sharma, Smitha Sammith Shetty and Raghu Radhakrishnan*

Synthesis and DFT study on Hantzsch reaction to produce asymmetrical compounds of 1,4-dihydropyridine derivatives for P-glycoprotein inhibition as anticancer agent

Shirin Mollazadeh, Fatemeh Moosavi, Farzin Hadizadeh, Mahmoud Seifi, Javad Behravan and Maryam Iman*